Products
Data
Feature
Plans
Request Demo
Sign Up for Free
Blog
Valuable Targets
Advanced Tech.
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
8 min read
GPR37 Biologics Sequence Review Report 2026: Prosaposin receptor GPR37 Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of GPR37 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
TNFRSF13B Biologics Sequence Review Report 2026: Tumor necrosis factor receptor superfamily member 13B Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of TNFRSF13B protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
8 min read
TNFRSF10C Biologics Sequence Review Report 2026: Tumor necrosis factor receptor superfamily member 10C Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of TNFRSF10C protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
TNFRSF10B Biologics Sequence Review Report 2026: Tumor necrosis factor receptor superfamily member 10B Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of TNFRSF10B protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
PTPRT Biologics Sequence Review Report 2026: Receptor-type tyrosine-protein phosphatase T Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of PTPRT protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
GPR171 Biologics Sequence Review Report 2026: G protein-coupled receptor 171 Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of GPR171 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CLDN4 Biologics Sequence Review Report 2026: Claudin-4 Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of CLDN4 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
IL18RAP Biologics Sequence Review Report 2026: Interleukin-18 receptor accessory protein Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of IL18RAP protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
TNFRSF11B Biologics Sequence Review Report 2026: Tumor necrosis factor receptor superfamily member 11B Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of TNFRSF11B protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
GPR31 Biologics Sequence Review Report 2026: 12-(S)-hydroxy-5,8,10,14-eicosatetraenoic acid receptor Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of GPR31 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
8 min read
TNFRSF10A Biologics Sequence Review Report 2026: Tumor necrosis factor receptor superfamily member 10A Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of TNFRSF10A protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
8 min read
TLR2 Biologics Sequence Review Report 2026: Toll-like receptor 2 Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of TLR2 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
<
1
<<
599
600
601
602
603
>>
1905
>